We found decreased concentrations of serum IgG (Figure 2A), IgA (Figure 2B), but not IgM (Figure 2C) in the group of critically ill patients, who survived COVID-19 (group C) compared to the other groups; however, these differences were not statistically significant. The gene discussed is CD79A; the disease is COVID-19.